Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of nebivolol hydrochloride tablets in adults with mild to moderate essential hypertension
CTR20260928Phase 3Active
- Sponsor
- Zhejiang Garden Pharmaceutical
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in essential hypertension, sponsored by Zhejiang Garden Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
nebivolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20260928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260928.